Sponsor Pipeline

Li Zhiming Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06985472 Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL Initial MZL Recruiting
NCT06890585 Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in… BTK Inhibitors Not Yet Recruiting
NCT07231250 Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed… DLBCL - Diffuse Large B Cell Lymphoma Not Yet Recruiting
Disease Areas
DLBCL (2)
Get alerts when Li Zhiming's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free